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Abstract
Conventional drug delivery systems usually involve the intake of multiple drugs, which could amplify the risk of overdosing. Acetaminophen is a widely used pain relief substance that is prone to accidental overdosing. Hence, a controlled
drug delivery system is needed to ensure its efficacy. A nanocomposite hydroxyapatite/alginate system that was used as
a drug carrier for acetaminophen was synthesized through the sol-gel method, and the mechanism underlying its controlled
drug delivery was investigated. Spherical nanocomposite bead samples were synthesized by incorporating 5 wt%, 10
wt%, and 15 wt% hydroxyapatite into mixtures containing alginate. The mixtures were then dropped into calcium chloride
solution. The phase purity of the hydroxyapatite sample was confirmed through X-ray diffraction, and the functional
groups that confirmed the presence of alginate and hydroxyapatite in the nanocomposite samples were analyzed by using
Fourier transform infrared spectroscopy. The release of acetaminophen can be controlled for 48 h, and the Korsmeyer–
Peppas kinetics model showed the best correlation for all samples. The kinetics of Al/HAp5, Al/HAp10, and Al/HAp15
were governed by quasi-Fickian diffusion with the n values of 0.199, 0.238, and 0.225, respectively. The composite beads
show potential for application as a controlled drug delivery vehicle.
Keywords: acetaminophen, alginate, diffusion, hydroxyapatite, release

and reducing the side effects of the drugs based on their
ability to target specific sites only [4].

Introduction
Traditionally, the administration of medical drugs to gain
therapeutic benefits is done by consuming these drugs
through several routes, such as inhalation, and oral and
transdermal administration. However, despite having been
proven to be successful in delivering pharmacological
substances, conventional drug delivery systems still have
drawbacks in controlling the rate of drug delivery to the
targeted site [1]. Conventional drug delivery systems are
associated with the high likelihood of drug overdose due
to repeated and voluntarily drug consumption. Moreover,
the distribution of unnecessarily high doses to nontargeted
body cells and tissues may result in serious adverse
effects during treatment [2]. One of the commonly
consumed drugs for treatment is acetaminophen, which
is used as an analgesic and anti-inflammatory treatment
for headaches, colds, or common pain. The U.S. Food
and Drug Administration reported that acetaminophen
overdose has become the most common cause of liver
transplantation, with 50% of cases caused by accidental
overdosing [3]. Therefore, the development of drug
delivery technologies is needed to overcome the setbacks
of conventional drug delivery. Controlled drug delivery
systems are effective in ensuring high therapeutic effects

Often, in controlled drug delivery systems, an inorganic
material, such as hydroxyapatite, is used as the drug
carrier through electrostatic interaction and hydrogen
bonding. Hydroxyapatite is a naturally occurring calcium
phosphate mineral and is widely known as the main
component of bone [5]. The attractive properties possessed
by hydroxyapatite for utilization as a drug delivery
vehicle are low solubility at physiological pH, porosity,
and porous structure that can absorb high amounts of
therapeutic substances and maintain sustained release [5].
Hydroxyapatite can undergo surface electrostatic and
hydrophobic interactions with drug molecules [5]. Hence,
increasing the loading of hydroxyapatite prolongs drug
release due to the availability of additional active sites that
could improve electrostatic and hydrophobic interactions
[6]. Meanwhile, alginate, which is usually derived from
brown seaweed, is known as a biocompatible, biodegradable, nontoxic, versatile material that can be shaped
into various scaffolds to enhance cell differentiation [7].
Biopolymers, such as alginate, usually exhibit a mucoadhesive property that is advantageous for extending the
contact time of therapeutic substances with the mucous
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September 2022  Vol. 26  No. 3

Synthesis of Alginate/Hydroxyapatite Beads

layer in the gastrointestinal track, thus prolonging and
sustaining substance release [8]. The combination of
alginate and hydroxyapatite has been used as a drug
delivery vehicle for ciprofloxacin [9], gentamicin [10],
amoxicillin [11], doxorubicin [12, 13], tetracycline
hydrochloride [14], chlorhexidine [15], propranolol [16],
and cloxacillin [16]. Acetaminophen is widely used as the
first-line treatment of mild to chronic or persistent pain. It
is usually taken multiple times a day (every 4––6 h) and
is immediately released [17]. Hence, the sustained release
of acetaminophen improves convenience and compliance
among patients and enhances pain relief [17, 18]. The
combination of hybrid organic–inorganic systems for
drug delivery has provided a multipurpose system that
offers advantages, such as improved drug retention,
controlled release for targeted therapeutic strategy, and
superior pharmacokinetics properties [19]. Given that the
combination of alginate and hydroxyapatite has not been
applied for the delivery of acetaminophen, this study
aims to reveal the performance of this composite in the
controlled release of acetaminophen and the kinetics
model that fits the release profile of acetaminophen.

Methods
Materials. Calcium nitrate tetrahydrate (Ca[NO3]2·4H2O),
diammonium hydrogen phosphate ([NH4]2HPO4),
sodium hydroxide (NaOH), and acetaminophen were
purchased from Sigma Aldrich. Hydrochloric acid (HCl,
37%) was purchased from Merck. Phosphate-buffered
saline (PBS), calcium chloride (CaCl2), and sodium
alginate were purchased from Fisher International.
Deionized water was used for preparing solutions and
washing. All chemicals were used as purchased without
further purification.
Synthesis of hydroxyapatite. Hydroxyapatite was prepared with Ca(NO3)2·4H2O dissolved in 50 ml of 0.4 M
HCl solution and (NH4)2HPO4 dissolved in 500 ml of 0.7
M NaOH solution. The Ca/P ratio was set as 1.67. At
room temperature, (NH4)2HPO4 was added dropwise into
the Ca(NO3)2·4H2O solution. The resulting sol was then
filtered by using vacuum filtration and repeatedly washed
with deionized water three times. The precipitate was
collected by drying the sol in the oven overnight at 100
°C. The dried particles were then grounded into a fine
powder by using a mortar and pestle.
Synthesis of hydroxyapatite–alginate beads. Beadshaped adsorbents were prepared by following a method
from a previous study with some modifications [20].
First, approximately 5 wt% hydroxyapatite was mixed
with 1 wt% sodium alginate solution. Mixing was repeated with 10 wt% and 15 wt% hydroxyapatite. By using a syringe, the mixture was then dropped into the
CaCl2 solution at the concentration of 10 g/L. The beads
from the solution were filtered and dried in an oven at 40
°C for 5 h.
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Characterization of the synthesized material. The
phase purity and structure of hydroxyapatite were
analyzed by using an X-ray diffractometer (XRD, Bruker
D8 Advance) on an X'Pert3 Powder & Empyrean
PANalytical system with Cu Kα irradiation (λ = 1.54),
diffraction angles (2θ) ranging from 10° to 80°, the step
size of 1°/step, and the exposure time of 1 s/step. The
functional groups present on the surfaces of the
hydroxyapatite and beads were analyzed by using Fourier
transform infrared (FTIR, Perkin Elmer) spectroscopy
over the wavenumber range of 500–4000 cm−1.
Acetaminophen loading and release test. Acetaminophen
was dispersed into the mixture of hydroxyapatite and
sodium alginate at the concentration of 20 ppm. By using
a syringe, the mixture containing acetaminophen was
dropped into CaCl2 at the concentration of 10 g/L. The
resulting beads from the mixture were then filtered
through vacuum filtration and washed three times with
deionized water. The beads were filtered and dried in an
oven at 40 °C for 5 h. The products prepared with 5 wt%,
10 wt%, and 15 wt% hydroxyapatite were designated as
Al/HAp5, Al/HAp10, and Al/HAp15, respectively. The
dried beads were then used for the release test. The
remaining acetaminophen solution was then analyzed by
using a UV–Vis spectrophotometer (Shimadzu UV–
1800) to determine the amount of acetaminophen loaded
in the composite beads.
Al/HAp5, Al/HAp10, and Al/HAp15 were added into 25
mL of PBS separately. The three mixtures were then
shaken at the speed of 250 rpm by using an orbital shaker
with the temperature kept at 37 °C. Approximately 3 mL
of the solution was taken periodically over 2 days to check
for absorbance by using a UV–Vis spectrophotometer
(Shimadzu UV–1800) at the wavelength of 243 nm. The
sample solution was taken at the following time points:
15 min, 30 min, 1 h, 2 h, 4 h, 8 h, 24 h, and 48 h. Every
3 mL of sample taken was replaced with the same amount
of fresh PBS. Cumulative drug release (CDR) was then
calculated by using the formula
𝐶𝐷𝑅(%) =

𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝐴𝑐𝑒𝑡𝑎𝑚𝑖𝑛𝑜𝑝ℎ𝑒𝑛 𝑎𝑡 𝑡𝑖𝑚𝑒,𝑡
𝑀𝑎𝑥𝑖𝑚𝑢𝑚 𝑙𝑜𝑎𝑑𝑖𝑛𝑔 𝑐𝑜𝑛𝑡𝑒𝑛𝑡

× 100%.

The graph of CDR against time was plotted. The curves
of the graph were fitted to several kinetics models for
analyzing the drug release mechanism.
Kinetics analysis. The drug release kinetics based on the
zero-order kinetics model was analyzed by using Equation (1) [21]:
𝐶𝑡 = 𝐶0 + 𝐾0 𝑡,

(1)

where Ct is the concentration of the drug remaining at
time t, C0 is the initial concentration of the drug, and K0
is the zero-order rate constant. The drug release kinetics
September 2022  Vol. 26  No. 3
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for the first-order kinetics model was analyzed by using
Equation (2) [21]:
log 𝐶𝑡 = log 𝐶𝑜 −

𝐾1 𝑡

,

2.303

into the mixture. Hence, the particle diameter slightly increased with the increase in the weight of the mixture.

(2)

in which K1 is the first-order rate constant. Drug release
kinetics for the Higuchi kinetics model was analyzed on
the basis of Equation (3) [21]:
1

𝑄 = 𝐾𝐻 × 𝑡 2 ,

(3)

where Q is the cumulative amount of drug released, and
KH is the Higuchi dissolution constant. The drug release
kinetics based on the Hixson–Crowell kinetics model
was analyzed by using Equation (4) [21]:
1/3

𝐶𝑜

1

− 𝐶𝑡3 = 𝐾𝐻𝐶 𝑡,

(4)

where KHC is the Hixson–Crowell rate constant. The drug
release kinetics based on the Korsmeyer–Peppas kinetics
model was analyzed by using Equation (5) [21]:
𝑀𝑡
⁄𝑀 = 𝑘. 𝑡 𝑛 .
𝛼

(5)

in which Mt/Mα is the fraction of the drug released at time
t, k is the rate constant, and n is the release exponent indicating the drug transport mechanism through the polymer.

Results and Discussion
Morphology. The hydroxyapatite powder (Figure 1a)
was synthesized through the sol-gel method, which is
also known as wet chemical precipitation. The selected
method has been proven to be advantageous in achieving
high-purity nanoparticles at low temperatures and ambient
pressures [22]. It involves the chemical transformation of
the colloidal suspension of particles, namely, sol, followed
by gelation to form a gel [23]. In the synthesis of the
alginate–hydroxyapatite composite, the sol-gel transition
occurred immediately after the mixture of alginate–
hydroxyapatite was dropped into the CaCl2 solution to
produce beads.
The average diameters of the Al/HAp5, Al/HAp10, and
Al/HAp15 beads after synthesis were 2–3, 2–3.5, and
3.5–4 mm, respectively (Figure 1b–d). Evidently, the
bead size of Al/HAp15 was slightly larger than that of the
other composite beads. During the sol-gel transition, Ca2+
ions penetrated the alginate and interacted with PO43[24]. The hydroxyapatite particles then grew slowly
among the alginate polymer chains [24]. The swelling of
these beads was mostly influenced by the interaction
among hydroxyapatite, alginate, and acetaminophen particles, as well as the amount of each component added
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Figure 1. Measurements of a) Synthesized Hydroxyapatite,
b) Al/HAp5, c) Al/HAp10, and d) Al/HAp–15
Beads. The Measurements Were Taken by using
a Ruler in Units of cm.

Figure 2. XRD Spectrum of the Synthesized Hydroxyapatite
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Crystallinity and functional groups. The phase purity
of hydroxyapatite was analyzed by using an XRD Xpert–
3 system. The hydroxyapatite phase was identified on the
basis of the measurement of the diffracted beam intensities at their respective diffraction angles. The diffraction
patterns contained peaks at 2θ 25.87°, 32.07°, 39.92°,
46.83°, 49.53°, and 53.21° that corresponded to the diffraction planes of (002), (211), (310), (222), (213), and
(004), respectively (Figure 2) [23, 25], based on the
standard data for hydroxyapatite diffraction peaks provided in JCPDS 09–0432. The appearance of these prominent sharp peaks confirmed the presence of pure crystalline hydroxyapatite, Ca10(PO4)6(OH)2, as a single phase
with a hexagonal structure.
The FTIR spectra of hydroxyapatite, Al/HAp5, Al/HAp10,
and Al/HAp15 are shown in Figure 3a. The wide
absorption peaks at 3262–3267 cm−1 for all Al/HAp
samples were due to the stretching vibrations of O–H
bonds in the presence of alginate. The band at 1605 cm−1
was assigned to the asymmetric C=O stretching of
alginate [26]. The absorption peak at 1408 cm−1 can be

Figure 3. a) FTIR Spectra and b) Enlarged FTIR Spectra
of Alginate, Hydroxyapatite, and Al/HAp
Samples
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assigned to the symmetric stretching vibration of
carboxylate anions (COO−) [27]. The band at 1326 cm-1
corresponded to C–O stretching vibration [28]. The absorption at peak 1082 cm−1 corresponded to C–O stretching vibrations (C–O–C) [9]. The overlapping absorbance
peaks of hydroxyapatite and alginate at 1020 cm−1 can be
assigned to the phosphate group(PO43−) of hydroxyapatite [23] and C–O–C asymmetric stretching in alginate
[27] (Figure 3b). The intensity of the peak at 1020 cm −1
slightly increased due to the addition of hydroxyapatite
in the beads and can confirm the increased loading of hydroxyapatite in the beads (Figure 3b). Hydroxyapatite
and alginate could interact through Ca–OH groups on the
apatite surface [29]. All peaks correlated with alginate
appeared in the spectra of Al/Hap. Hence, no chemical
change occurred during the fabrication of the composite.
Drug release and kinetics. In this experiment,
acetaminophen was loaded during bead synthesis to
maximize drug loading. The loading amounts of
acetaminophen in Al/Hap5, Al/Hap10, and Al/Hap15
were 76.3%, 86.5%, and 90.2%, respectively. The
increased loading of hydroxyapatite provided additional
sites for the adsorption of acetaminophen [30, 31]. Figure
4 shows the cumulative acetaminophen release from the
synthesized beads. Acetaminophen release increased in
parallel with its respective absorbance with the
prolongation of the release time. The CDR data showed
that Al/HAp5 took only 2 h to release 51.10% of
acetaminophen, whereas Al/HAp10 and Al/HAp15 took
8 and 4 h to release 53.57% and 50.76% of acetaminophen,
respectively. Moreover, the early-stage release of
acetaminophen from Al/HAp5 occurred at a more rapid
rate than that from Al/HAp10 and Al/HAp15. The
incorporation of hydroxyapatite provided additional
available actives sites for electrostatic and hydrophobic
interactions in the alginate matrix that helped retain

Figure 4. Profile of Acetaminophen Release from Al/HAp
Samples
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acetaminophen [5]. Hence, as can be deduced from the
release profile, HAp-Alg-AC–10 was the optimal
nanocomposite for acetaminophen release because it
exhibited the most controlled, sustained, and slow
acetaminophen release. Meanwhile, the excessive addition
of hydroxyapatite might cause the formation of additional
microchannels in the composites and thus hastened the
release of acetaminophen [24]. Chen et al. found similar
results for the loading and release of alendronate from
composite hydroxyapatite microspheres [30]. The

increased loading of hydroxyapatite provided additional
active sites for increased drug adsorption; as a result,
sustained drug release by the microspheres with
hydroxyapatite was nearly five times higher than that
from the microspheres without hydroxyapatite loading
[30]. Pradid et al. improved the clindamycin loading and
nontoxicity toward human lung fibroblast cells of
PLA/hydroxyapatite microspheres by increasing the
amount of hydroxyapatite in the composites [31].

Figure 5. a) Zero-order, b) First-order, c) Higuchi, d) Hixson–Crowell, and e) Korsmeyer–Peppas Drug Release Kinetics Models

Makara J. Sci.
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Table 1. Correlation Coefficients of Kinetics Models

Kinetics Model

Correlation Coefficient (R2)
Al/HAp5

Al/HAp10

Al/HAp15

Zero-order

0.637

0.808

0.740

First-order

0.880

0.924

0.959

Higuchi

0.886

0.989

0.985

Hixson–Crowell

0.718

0.879

0.827

Korsmeyer–Peppas

0.916

0.972

0.972

The CDR of each sample was fitted to the zero-order,
first-order, Higuchi, Hixson–Crowell, and Korsmeyer–
Peppas kinetics models. The plots shown in Figure 5
were used to determine the behavior of acetaminophen
release from the nanocomposite beads. The correlation
coefficients obtained from the kinetics models are
provided in Table 1. The correlation coefficient values
indicated that the best correlation with all samples was
shown by the Korsmeyer–Peppas model, wherein drug
release occurred through quasi-Fickian diffusion from
polymer matrices through the membrane to receptor
mediaas illustrated by the release exponent (n) values of
0.199, 0.238, and 0.225 for Al/HAp5, Al/HAp10, and
Al/HAp15, respectively [21]. The value of n describes
the types of diffusion, wherein a value less than 0.45
corresponds to the Fickian diffusion mechanism, which
is governed by the gradient of chemical potential or
differences in concentrations [32]. The release of
acetaminophen can be accompanied by minor swelling or
friction inside the beads [33]. The release rate constant k
was approximately 5.11, 4.69, and 4.93 for Al/HAp5,
Al/HAp10, and Al/HAp15, respectively. The release rate
constant showed a narrow range of values for all types of
beads, with the increased loading of hydroxyapatite
resulting in sustained drug release by reducing the release
rate constant. Previous research on the utilization of
inorganic materials used hydroxyapatite to administer
acetaminophen and demonstrated that acetaminophen
loading reached 48.5% and that most of the drug was
released after 8 h [23]. The combination of organic and
inorganic materials showed highly promising results. In
a previous study, acetaminophen release can be sustained
for up to 200 h by using glass–ceramic porous scaffolds
coated with chitosan [34].

Conclusions
The alginate–hydroxyapatite samples were fairly capable
of producing a steady increment in drug release rate with
the increase in hydroxyapatite amount. The addition of
hydroxyapatite could provide additional active sites in
the beads that could help retain acetaminophen and
prolong drug release. The release of acetaminophen from
the solid matrices can be maintained for 48 h and was
Makara J. Sci.

governed by the Fickian diffusion mechanism. Therefore,
the combination of hydroxyapatite and alginate has
potential applications in the biomedical field as a drug
carrier medium to achieve a controlled drug delivery
system.
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